Page last updated: 2024-08-25

imidazo(1,2-a)pyridine and Leukemia, Myeloid, Acute

imidazo(1,2-a)pyridine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bharate, JB; Frett, B; Kharbanda, A; Lakkaniga, NR; Leung, YK; Li, HY; Mcconnell, N; Shah, NP; Wang, X; Zhang, L1

Other Studies

1 other study(ies) available for imidazo(1,2-a)pyridine and Leukemia, Myeloid, Acute

ArticleYear
Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor.
    European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Molecular Structure; Mutation; NIMA-Related Kinases; Protein Kinase Inhibitors; Pyridines; Structure-Activity Relationship; Thiophenes

2021